LIGAN
Lauriane Le Collen et al.
Heterozygous pathogenic variants in POMC are not responsible for monogenic obesity: Implication for MC4R agonist use
Genetics in Medicine 2023, vol. 25, issue 7
doi: 10.1016/j.gim.2023.100857
Sadia Saeed et al.
Biallelic Mutations in P4HTM Cause Syndromic Obesity
Diabetes 2023, vol. 72, issue 9
doi: 10.2337/db22-1017
Alice Capuz et al.
Astrocytes express aberrant immunoglobulins as putative gatekeeper of astrocytes to neuronal progenitor conversion
Cell Death & Disease 2023, vol. 14, issue 4
doi: 10.1038/s41419-023-05737-9
Lise Folon et al.
Contribution of heterozygous PCSK1 variants to obesity and implications for precision medicine: a case-control study
The Lancet Diabetes & Endocrinology 2023, vol. 11, issue 3
doi: 10.1016/s2213-8587(22)00392-8
Philippe Froguel et al.
The discovery of human agouti-induced obesity and its implication for genetic diagnosis
Nature Metabolism 2022, vol. 4, issue 12
doi: 10.1038/s42255-022-00695-6
P. Froguel et al.
Avancées et promesses de la médecine de précision personnalisée des maladies métaboliques
Bulletin de l'Académie Nationale de Médecine 2022, vol. 207, issue 2
doi: 10.1016/j.banm.2022.11.012
Cyril Bourouh et al.
The transcription factor E2F1 controls the GLP-1 receptor pathway in pancreatic β cells
Cell Reports 2022, vol. 40, issue 6
doi: 10.1016/j.celrep.2022.111170
Alexandre Pelletier et al.
Epigenetic and Transcriptomic Programming of HSC Quiescence Signaling in Large for Gestational Age Neonates
International Journal of Molecular Sciences 2022, vol. 23, issue 13
doi: 10.3390/ijms23137323
Amélie Bonnefond et al.
Achievements, prospects and challenges in precision care for monogenic insulin-deficient and insulin-resistant diabetes
Diabetologia 2022, vol. 65, issue 11
doi: 10.1007/s00125-022-05720-7
Madleen Lemaitre et al.
Management of pregnancy in a patient with congenital hyperinsulinism treated with association of diazoxide/calcium channel blocker
Acta Diabetologica 2022, vol. 59, issue 8
doi: 10.1007/s00592-022-01898-9
Commentaires